FUNI · Hypha Labs, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $114.4K | $185.9K | $81.7K | $65.5K | $1.03M | $486.2K | $182.5K | $14.7K | $8.8K | $45.7K |
| Total Operating Expenses | $420.4K | $475.0K | $536.0K | $669.2K | $1.31M | $613.6K | $574.0K | $70.6K | $95.3K | $174.1K |
| D&A | $1.8K | $2.0K | - | - | $1.4K | - | - | - | - | - |
| Operating Income | ($420.4K) | ($475.0K) | ($536.0K) | ($669.2K) | ($1.31M) | ($613.6K) | ($574.0K) | ($70.6K) | ($95.3K) | ($174.1K) |
| Interest Expense | $100.7K | $46.6K | $26.0K | $74.0K | $22.4K | $21.6K | $74.0K | $84.3K | $97.7K | $82.7K |
| Income Tax | - | - | - | - | - | ($22.7K) | $48.7K | - | - | - |
| Net Income | ($521.1K) | ($521.6K) | ($562.0K) | ($641.8K) | ($1.34M) | ($706.9K) | $235.8K | $151.6K | $293.5K | ($67.5K) |
| EPS - Basic | $0.00 | $0.00 | $0.00 | ($0.01) | ($0.01) | ($0.01) | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS - Diluted | $0.00 | $0.00 | $0.00 | ($0.01) | ($0.01) | ($0.01) | $0.00 | $0.00 | $0.00 | $0.00 |
Balance Sheet
| Line item | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $82.2K | $42.9K | $38.1K | $21.1K | $36.6K | $91.2K | $1.06M | $308.3K | $271.0K | $115.9K |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $630.3K | $546.9K | $472.6K | $330.6K | $143.9K | $86.3K | $102.1K | $92.2K | $122.1K | $248.9K |
| Current Assets | $96.4K | $314.6K | $320.5K | $187.0K | $177.7K | $410.2K | $1.39M | $872.4K | $765.8K | $486.0K |
| Total Assets | $159.8K | $391.6K | $409.2K | $257.0K | $258.6K | $493.8K | $1.39M | $1.52M | $1.41M | $1.11M |
| Current Liabilities | $1.43M | $1.32M | $2.51M | $1.73M | $1.47M | $1.39M | $1.52M | $3.09M | $3.12M | $3.48M |
| Long-term Debt | $1.84M | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $2.94M | $2.74M | $2.51M | $1.74M | $1.49M | $1.42M | $1.52M | $3.24M | $3.28M | $3.69M |
| Stockholders' Equity | ($3.12M) | ($2.69M) | ($2.44M) | ($1.82M) | ($1.56M) | ($1.26M) | ($471.7K) | ($2.05M) | ($2.21M) | ($2.91M) |
| Retained Earnings | ($24.69M) | ($24.17M) | ($23.65M) | ($22.53M) | ($21.89M) | ($20.55M) | ($19.37M) | ($19.61M) | ($19.76M) | ($20.32M) |
Cash Flow
| Line item | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | ($150.2K) | - | - | ($8.0K) | - | - | $64.7K | - | - |
| Investing Cash Flow | - | - | - | - | ($1.7K) | - | - | ($11.7K) | - | - |
| Financing Cash Flow | - | $155.0K | - | - | ($44.9K) | - | - | ($15.8K) | - | - |
| CapEx | - | - | - | - | $1.7K | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | ($9.7K) | - | - | - | - | - |
Ratios
| Metric | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | 0.01 | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | 17.1% | - | - | - |
| Return on assets | -326.1% | -133.2% | -137.3% | -249.8% | -517.9% | -143.2% | 17.0% | 10.0% | 20.8% | -6.1% |
| Return on equity | 16.7% | 19.4% | 23.1% | 35.3% | 85.6% | 56.1% | -50.0% | -7.4% | -13.3% | 2.3% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.07 | 0.24 | 0.13 | 0.11 | 0.12 | 0.29 | 0.91 | 0.28 | 0.25 | 0.14 |
| Quick ratio | 0.07 | 0.24 | 0.13 | 0.11 | 0.12 | 0.29 | 0.91 | 0.28 | 0.25 | 0.14 |
| Cash ratio | 0.06 | 0.03 | 0.02 | 0.01 | 0.02 | 0.07 | 0.70 | 0.10 | 0.09 | 0.03 |
| Leverage | ||||||||||
| Debt / Equity | -0.59 | - | - | - | - | - | - | - | - | - |
| Debt / Assets | 11.51 | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -4.2x | -10.2x | -20.6x | -9.0x | -58.3x | -28.4x | -7.8x | -0.8x | -1.0x | -2.1x |
| Equity multiplier | -0.05 | -0.15 | -0.17 | -0.14 | -0.17 | -0.39 | -2.94 | -0.74 | -0.64 | -0.38 |
| Liabilities / Assets | 18.41 | 7.00 | 6.14 | 6.77 | 5.76 | 2.88 | 1.10 | 2.13 | 2.33 | 3.31 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 37.2% | 63.6% | 12.6% | -16.6% | -1749.8% | -544.2% | -229.7% | 18.2% | 39.8% | 44.4% |
| Net income growth (YoY) | 18.8% | 61.1% | 20.5% | - | - | - | - | - | - | 81.9% |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -71.5% | -71.6% | -93.3% | -285.3% | 23.8% | 42.8% | 83.8% | 28.8% | 19.6% | -62.8% |
Peer comparison
Same SIC group: Services-Testing Laboratories
Comparing Hypha Labs against the 4 most active filers in the same SIC group.